New drug product development is a highly challenging process; manufacturing a nano-vectorization of a potent active pharmaceutical ingredient (API) is even more demanding. Managing the full supply chain of such processes can be considered rocket science.
We support our partners through the various steps of new drugs development!
We expertly manage the challenge of cGMP nano-vectorization and overcome the hurdles that are intrinsic to the development of such molecules, allowing our partners to focus on their core business: drug discovery. In the contract development and manufacturing organization (CDMO) environment, V-Nano is a real alternative for such drug products and provide support for: